$HALB's new virus treatment methodology entails using a specifically created antibody conjugated with a radio frequency reactive moiety which binds with the target antigen in an extracorporeal mixing chamber. The conjugation-irradiation-filtration process would be conducted in real-time on a continuous flow basis, much like kidney dialysis. https://finance.yahoo.com/news/halberd-corpor...00599.html